Fertility after ectopic pregnancy: The DEMETER randomized trial

Human Reproduction

Volumn 28, Issue 5, 2013, Pages 1247-1253

  Fernandez, Hervé ^a,b,c,d   Capmas, Perrine ^a,b,d   Lucot, Jean Philippe ^e   Resch, Benoit ^f   Panel, Pierre ^g   Bouyer, Jean ^a,d  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b BICÊTRE HOSPITAL   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f HÔPITAL CHARLES NICOLLE   (France)

^g CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

ectopic pregnancy; laparoscopy; randomized controlled trials

Indexed keywords

CHORIONIC GONADOTROPIN; METHOTREXATE; PROGESTERONE;

ADULT; CONSERVATIVE TREATMENT; CONTROLLED STUDY; ECTOPIC PREGNANCY; FEMALE; FEMALE FERTILITY; FOLLOW UP; GESTATIONAL AGE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVULATION INDUCTION; PARITY; POSTOPERATIVE PERIOD; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; SALPINGECTOMY;

EID: 84876551487     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det037     Document Type: Review

References (31)

1. Akira S, Negishi Y, Abe T, Ichikawa M, Takeshita T. Prophylactic intratubal injection of methotrexate after linear salpingostomy for prevention of persistent ectopic pregnancy. J Obstet Gynaecol Res 2008; 34: 885-889.
2. Allonier C, Ego A, Gerbaud L, Job-Spira N, Subtil D, Bouyer J. Comparison of fertility rates after ectopic pregnancy in Auvergne and Lille regions. J Gynecol Obstet Biol Reprod 2003;32: 439-446. (Pubitemid 37101583)
3. Baird DD, Wilcox AJ, Weinberg CR. Use of time to pregnancy to study environmental exposures. Am J Epidemiol 1986;124: 470-480. (Pubitemid 16047363)
4. Beall S, DeCherney A. Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility. Fertil Steril 2012;98: 1118-1120.
5. Bernoux A, Job-Spira N, Germain E, Coste J, Bouyer J. Fertility outcome after ectopic pregnancy and use of an intrauterine device at the time of the index ectopic pregnancy. Hum Reprod 2000;15: 1173-1177. (Pubitemid 30251321)
6. Bouyer J, Job-Spira N, Pouly JL, Coste J, Germain E, Fernandez H. Fertility following radical, conservative-surgical or medical treatment for tubal pregnancy: a population-based study. BJOG 2000;107: 714-721. (Pubitemid 30311905)
7. Bouyer J, Fernandez H, Coste J, Pouly J-L, Job-Spira N. Fertility after ectopic pregnancy: 10-year results in the Auvergne Registry. J Gynecol Obstet Biol Reprod 2003;32: 431-438. (Pubitemid 37101582)
8. Canis M, Savary D, Pouly J-L, Wattiez A, Mage G. Ectopic pregnancy: criteria to decide between medical and conservative surgical treatment?. J Gynecol Obstet Biol Reprod 2003;32: S54-S63.
9. Carson SA, Buster JE. Ectopic pregnancy. N Engl J Med 1993; 329: 1174-1181.
10. da Costa Soares R, Elito J Jr, Camano L. Increment in beta-hCG in the 48-h period prior to treatment: a new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate. Arch Gynecol Obstet 2008;278: 319-324.
11. de Bennetot M, Rabischong B, Aublet-Cuvelier B, Belard F, Fernandez H, Bouyer J, Canis M, Pouly JL. Fertility after tubal ectopic pregnancy: results of a population-based study. Fertil Steril 2012;98: 1271-1276.
12. Dias Pereira G, Hajenius PJ, Mol BW, Ankum WM, Hemrika DJ, Bossuyt PM, van der Veen F. Fertility outcome after systemic methotrexate and laparoscopic salpingostomy for tubal pregnancy. Lancet 1999;353: 724-725. (Pubitemid 29103813)
13. Dilbaz S, Caliskan E, Dilbaz B, Degirmenci O, Haberal A. Predictors of methotrexate treatment failure in ectopic pregnancy. J Reprod Med 2006;51: 87-93. (Pubitemid 43277276)
14. Fernandez H, Lelaidier C, Thouvenez V, Frydman R. The use of a pretherapeutic, predictive score to determine inclusion criteria for the non-surgical treatment of ectopic pregnancy. Hum Reprod 1991; 6: 995-998.
15. Fernandez H, Yves Vincent S, Pauthier S, Audibert F, Frydman R. Randomized trial of conservative laparoscopic treatment and methotrexate administration in ectopic pregnancy and subsequent fertility. Hum Reprod 1998;13: 3239-3243. (Pubitemid 28521881)
16. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1982;1: 121-129. (Pubitemid 13146129)
17. Graczykowski JW, Mishell DR Jr. Methotrexate prophylaxis for persistent ectopic pregnancy after conservative treatment by salpingostomy. Obstet Gynecol 1997;89: 118-122. (Pubitemid 27024480)
18. Hajenius PJ, Mol F, Mol BW, Bossuyt PM, Ankum WM, van der Veen F. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev 2009.
19. Hernández AV, Steyerberg EW, Habbema JDF. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol 2004;57: 454-460. (Pubitemid 38758048)
20. Kirk E, Van Calster B, Condous G, Papageorghiou AT, Gevaert O, Van Huffel S, De Moor B, Timmerman D, Bourne T. Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management. Acta Obstet Gynecol Scand 2010;90: 264-272.
21. Lipscomb GH, McCord ML, Stovall TG, Huff G, Portera SG, Ling FW. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 1999;341: 1974-1978. (Pubitemid 30010405)
22. Menon S, Colins J, Barnhart KT. Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review. Fertil Steril 2007;87: 481-484. (Pubitemid 46385986)
23. Nieuwkerk PT, Hajenius PJ, Van der Veen F, Ankum WM, Wijker W, Bossuyt PM. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal preganacy. Part II. Patient preferences for systemic methotrexate. Fertil Steril 1998;70: 518-522. (Pubitemid 28435637)
24. Olsen J, JuuL S, Basso O. Measuring time to pregnancy. Methodological issues to consider. Hum Reprod 1998;13: 1751-1753.
25. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 2002;21: 2917-2930.
26. Rabischong B, Tran X, Sleiman A, de Bennetot M, Rabischong B, Aublet-Cuvelier B, Belard F, Fernandez H, Bouyer J, Canis M et al. Predictive factors of failure in management of ectopic pregnancy with single-dose methotrexate: a general population-based analysis from the Auvergne Register, France. Fertil Steril 2011;95: 401-404.
27. Tawfiq A, Agameya AF, Claman P. Predictors of treatment failure for ectopic pregnancy treated with single-dose methotrexate. Fertil Steril 2000;74: 877-880.
28. van Mello NM, Mol F, Adriaanse AH, Boss EA, Dijkman AB, Doornbos JP, Emanuel MH, Friederich J, Leeuw-Harmsen Lv, Lips JP et al. The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial. BMC Womens Health 2008;8: 10.
29. Yao M, Tulandi T. Surgical and medical management of tubal and non-tubal ectopic pregnancies. Curr Opin Obstet Gynecol 1998; 10: 371-374. (Pubitemid 28487359)
30. Yu L-M, Chan A-W, Hopewell S, Deeks JJ, Altman DG. Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review. Trials 2010;11: 59.
31. Zilber U, Pansky M, Bukovsky I, Golan A. Laparoscopic salpingostomy versus laparoscopic local methotrexate injection in the management of unruptured ectopic gestation. Am J Obstet Gynecol 1996; 175: 600-602.